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Akstraet 
Ricin and Shiga toxin belong to a group of protein toxins with targets in the cytosol. These toxins consist of one moiety that binds the toxin molecule 
to cell surface receptors, and another enzymatically active moiety that enters the cytosol after endocytic uptake of the toxin. The toxins are of current 
interest in relation to disease and the construction of immunotoxins. Moreover, they have proven useful to investigate mechanisms ofendocytosis 
and to follow intracellular pathways of transport. Some of the recent results obtained with ricin and Shiga toxin are discussed. 
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1. Introduction 
The current research on protein toxins with intracellu- 
lar targets is of considerable interest for several reasons. 
A number of the protein toxins are produced by bacteria 
and are important for severe diseases caused by these 
organisms. This is, for instance, the case for diphtheria 
toxin, although vaccination of the population has helped 
to control this disease, and for pseudomonas toxin, teta- 
nus toxin, botulinum toxin, and Shiga toxin [14]. Shiga 
toxin is not only produced by Shigella dysenteriae, which 
is the infective agent in dysenteria, but Shiga-like toxins 
are also produced by E. coli, giving rise to infections and 
disease and being a serious health problem in several 
countries [1,2]. Knowledge about the toxins and their 
action on cells is important for the understanding of 
these diseases. Furthermore, protein toxins have long 
been used to construct immunotoxins and other toxin 
conjugates in attempts to find more efficient drugs in the 
therapy of cancer and other diseases [5]. Another impor- 
tant point is that the protein toxins are very attractive 
tools in modern cell biology, for instance, with respect 
to the study of protein translocation across membranes 
[1,6-9], protein internalization by endocytosis, orting 
along the endocytic pathway, and exocytosis [3,4]. 
In this article we will focus on the internalization and 
intracellular transport of the plant toxin, ricin, and the 
bacterial toxin, Shiga toxin, two of the toxins studied by 
our groups. The schematic structure of these proteins is 
shown in Fig. 1. Ricin, which binds to both glycoproteins 
and glycolipids with terminal galactose and therefore 
binds to a large number of different molecules at the cell 
surface (3 x 10 7 binding sites per cell (HeLa cells)), has 
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proven useful as a tool to follow membrane traffic in 
general [10-12]. On the other hand, Shiga toxin, a toxin 
which binds to certain glycolipids (Gb3) [13] and is inter- 
nalized from clathrin-coated pits [14,15], has given us 
insight into a new pathway in the cell, a pathway that 
leads all the way from the cell surface, through the Golgi 
apparatus and to the endoplasmic reticulum from where 
the toxin may enter the cytosol [7]. 
2. Mechanisms of endocytosis 
Structural studies with ricin reveal that this molecule 
is bound all over the cell surface. This can be shown by 
EM, using ricin-gold conjugates or ricin bound to the 
enzyme, horseradish peroxidase (HRP) [10,11]. The en- 
docytic uptake of ricin is relatively slow compared to e.g. 
the uptake of transferrin, a ligand which, after binding 
to its receptor, is internalized via clathrin-coated pits and 
vesicles. Based on EM studies with a ricin-gold conju- 
gate it was clear that ricin also, at least in part, was 
located in clathrin-coated pits. This, however, did not 
exclude the possibility that a significant fraction of endo- 
cytosed ricin could be internalized by another mecha- 
nism. Depletion of cells for potassium in combination 
with a hypotonic hock strongly inhibited receptor-medi- 
ated internalization of LDL in human fibroblasts by 
removing clathrin-coated pits, or by preventing their for- 
mation [16]. Using a similar assay, we found that potas- 
sium depletion prevented internalization of transferrin, 
whereas ricin was still endocytosed, although at a re- 
duced rate [11]. Also, the toxin was still able to intoxicate 
cells [11,17]. Another way to interfere with the function 
of clathrin-coated pits is to acidify the cytosol. When the 
cytosolic pH falls below 6.5 the clathrin-coated pits be- 
come paralyzed at the cell surface; they can no longer 
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pinch off and form clathrin-coated vesicles [11,18]. This 
allowed us to look for other mechanisms of endocytosis 
that might not be affected by this treatment. Interest- 
ingly, in acidified cells ricin was still internalized at rates 
corresponding to 40-80% of the control value. Thus, in 
addition to the clathrin-dependent mechanism of endo- 
cytosis, a clathrin-independent mechanism is respons- 
ible for internalization of some molecules like ricin (see 
Fig. 2). 
By using ricin we have provided evidence for inde- 
pendent regulation of clathrin-independent endocytosis. 
In some cells it can be reduced by cytochalasin D [I 11, 
whereas in A43 1 cells clathrin-independent endocytosis 
can be up-regulated by epidermal growth factor (EGF) 
and TPA, a tumor promotor and activator of protein 
kinase C [ 11,19a]. Under these conditions there is no 
increase in the transferrin uptake, which takes place from 
clathrin-coated pits [11,19a]. Recently we have also ob- 
tained evidence for the presence of clathrin-independent 
endocytosis both on the apical and the basolateral side 
of polarized MDCK cells [ 19b]. Interestingly, physiolog- 
ical stimuli, like CAMP, seem to give a selective increase 
in clathrin-independent endocytosis at the apical side of 
these cells, suggesting an important function for this 
process in a polarized epithelium. 
The clathrin-coated vesicle and it’s components have 
been studied in considerable detail [20]. The vesicles re- 
sponsible for clathrin-independent endocytosis have so 
far not been isolated, and much less is known about this 
process. It seems likely that clathrin-independent endo- 
cytosis comprises more than one process since in some 
systems it gives rise to large vesicles [21], whereas in 
HEp-2 cells the pre-endosomal vesicles formed by 
clathrin-independent endocytosis has a diameter of 95 
nm, i.e. somewhat smaller than the clathrin-coated vesi- 
cles in these cells [22]. On the other hand, caveolae, small 
omega-shaped structures (SO-80 nm) at the cell surface, 
do not seem to be responsible for clathrin-independent 
endocytosis [23,24]. The main point, however, is that 
ricin is internalized by both clathrin-dependent and 
clathrin-independent mechanisms, and also the clathrin- 
independent pathway can lead to intoxication of the cells 
[ 10,l 1,171. In HEp-2 cells both pathways seem to lead to 
the same, transferrin receptor-enriched endosome com- 
partment [25]. However, although the pathways may 
merge in several cell types, this is not always the case. In 
rufIling A431 cells clathrin-independent endocytosis 
seems to give rise to vesicles that are able to fuse with 
each other and not with transferrin receptor-containing 
endosomes with low pH [26]. Also, when desmosomes 
are internalized by clathrin-independent endocytosis, the 
structures are not transferred to vesicles containing 
markers for late endosomes or lysosomes [27]. 
In contrast to ricin, Shiga toxin binds to a much more 
limited repertoire of cell surface molecules, namely neu- 
tral glycosphingolipids with terminal galal-4gal [13]. 
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Fig. 1. Schematic structure of ricin and Shiga toxin. 
Since endocytosis from clathrin-coated pits seems to re- 
quire a cytoplasmic signal [20], and since it has been 
suggested that both tetanus toxin and cholera toxin, 
which both bind to negatively charged glycolipids, are 
endocytosed by clathrin-independent endocytosis [28], 
we suspected that Shiga toxin would be slowly internal- 
ized by clathrin-independent endocytosis. However, ex- 
periments with immunogold detection of cell surface- 
bound Shiga toxin revealed that this toxin, surprisingly, 
is internalized predominantly or exclusively via clathrin- 
coated pits [ 14,151. This conclusion was supported by the 
finding that acidification of the cytosol prevented the 
endocytic uptake of the toxin. Aggregation of Shiga 
toxin in clathrin-coated pits may be due to interactions 
between the neutral glycolipid receptor and membrane 
or coat proteins, interactions strong enough to keep the 
glycolipid-receptor in clathrin-coated pits after cross- 
linking of the receptors by the multivalent oxin. 
Once internalized by clathrin-dependent endocytosis 
Shiga toxin is delivered to endosomes which we assume, 
although we have not performed direct immunogold 
double labelings at the EM level, are identical to those 
reached by internalized ricin. At least, Shiga-HRP conju- 
gates are delivered to an endosomal compartment with 
normal appearance in the EM [14,15]. 
3. nansport to the tram-Golgi network 
From the endosomal compartment endocytosed mole- 
cules may be (i) recycled back to the cell surface from 
where they came, (ii) delivered to lysosomes for degrada- 
tion, (iii) transcytosed to the opposite surface in polar- 
ized epithelia, or (iv) routed to the trans-Golgi network 
(TGN) (Fig. 2; for review, see [29]). We will not discuss 
the first two possibilities in the present review. However, 
transcytosis is relevant in relation to the application of 
e.g. immunotoxins. When ricin is internalized in polar- 
ized MDCK cells grown on filters, the toxin is actually 
transcytosed in an active form; it is still capable of inhib- 
iting protein synthesis in other cells [30]. 
Since there is evidence that ricin and Shiga toxin (and 
a number of other toxins as well) are transported to the 
trans-Golgi network as a necessary step on their way to 
the cytosol [7,29,31] this transport has been studied by 
several methods. By using EM one can visualize trans- 
port of toxin-HRP conjugates to the TGN, and quantifi- 
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Fig. 2. Toxins are endocytosed both by clathrin-dependent and -inde- 
pendent pathways, and ricin and Shiga toxin are transported to the 
TGN. Shiga toxin is also transported through the Golgi apparatus and 
to the endoplasmic reticulum [7]. 
cation by immunogold-labeling shows that 5-10% of the 
endocytosed toxin actually enters the TGN in 1 h [29]. 
Similar results are obtained by using cell fractionation 
performed on cells incubated with radioactively labeled 
toxin [8,15]. It should be mentioned that gold-labeled 
ricin is not transported to the TGN [29]; this conjugate 
is exclusively routed to the lysosomes. Also, multivalent 
conjugates of ricin and HRP were similarly routed to 
lysosomes [29]. Thus, the valency clearly affects the rout- 
ing, and it is therefore important to use monovalent 
conjugates. 
There are several ines of evidence suggesting that the 
Golgi apparatus is important for intoxication. At lower 
temperature (below lVC), when toxin transport to this 
organelle is inhibited [29,32], the cells are protected 
against ricin and Shiga toxin [29] but not against 
diphteria toxin, which is believed to enter the cytosol 
from endosomes upon acidification [33]. Also, hybrid- 
oma cells producing anti-&in antibody are protected 
against the toxin, presumably because ricin meets the 
antibody in the Golgi apparatus [34]. Recent evidence for 
the involvement of the Golgi apparatus comes from the 
finding that brefeldin A, a drug that disrupts the Golgi 
apparatus, protects against several of the protein toxins, 
including ricin and Shiga toxin [8,35]. It might be argued 
that this protection could be due to inhibition of trans- 
port of newly synthesized proteins to another organelle. 
However, protein synthesis is not required for intox- 
ication with ricin and Shiga toxin; rather, addition of 
cycloheximide to cells will make the transport to the 
cytosol more efficient [29]. Other results which support 
a role for the Golgi apparatus in the intoxication process 
are as follows: an amino acid sequence (KDEL) that is 
known as a retention signal for ER proteins was found 
to increase the toxicity of ricin A-chain [36]; and a similar 
sequence seems to be required for efficient intoxication 
with a related toxin, pseudomonas toxin [31,37]. Thus, 
although the exact location from where the toxins are 
translocated has not been determined, the Golgi appara- 
tus seems to play a central role. 
4. Retrograde transport from the Golgi to the ER 
Speculations have been made that several of the pro- 
tein toxins are transported to the ER before transloca- 
tion to the cytosol [7,8,31,37]. However, not until re- 
cently was such transport demonstrated [7]. A431 cells 
normally bind and internalize Shiga-HRP, but they are 
resistent to the toxin. However, after treatment of the 
A431 cells with butyric acid these cells became sensitive 
to Shiga toxin. At the same time, transport of internal- 
ized Shiga toxin (Shiga-HRP) to all cisterns of the Golgi 
stack, the ER and even the nuclear envelope was ob- 
served [7], supporting the idea that transport through the 
Golgi apparatus to the ER may be important for intoxi- 
cation, and for the first time demonstrating the existence 
of such a pathway (Fig. 2). More recently, a similar 
transport to the ER was demonstrated in cells originally 
very sensitive to Shiga toxin (Garred et al., submitted), 
showing that this pathway can operate also in non- 
treated cells. So far we have been unable to visualize 
transport of ricin to the ER. It is possible that so few 
molecules are transported to this location that the meth- 
ods currently available are not sensitive enough to dem- 
onstrate such a transport. It should be noted that neither 
Shiga toxin [38,39] nor ricin [40] contain a KDEL se- 
quence, however, the toxins may somehow interact with 
proteins with such a sequence. 
5. Future directions 
There are many important questions to be answered 
by future studies. How is clathrin-independent endocyto- 
sis regulated, and what are the roles of this pathway? 
Which sorting signals are required for retrograde trans- 
port of toxin through the Golgi apparatus to the ER? 
Furthermore, if the toxins are translocated to the cytosol 
from the ER, how does this occur? Is the translocation 
dependent on transport systems in the ER membrane, or 
some of the enzymes or proteins present in the ER 
lumen? What are the requirements for efficient transloca- 
tion, and how much modification of the molecule can be 
tolerated by the translocation apparatus? These ques- 
tions have to be answered to understand how the protein 
toxins exploit the cell machinery to reach the cytosol and 
kill the cells. Furthermore, the answers are important for 
further development of toxin conjugates designed to cure 
disease. Knowledge about the translocation machinery 
might also allow us to protect cells and organisms 
against the severe effects of the protein toxins. 
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